| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |